Status:
UNKNOWN
Glycemic Control and Retinal Microvascular Changes
Lead Sponsor:
Seoul National University Hospital
Conditions:
Diabetic Retinopathy
Neurodegeneration
Eligibility:
All Genders
30-70 years
Brief Summary
The goal of this prospective, observational study is to compare in the association of glycemic control and retinal microvascular changes in patients with type 2 diabetes mellitus (T2DM) without diabet...
Eligibility Criteria
Inclusion
- The study included 30-70-year-old patients with T2DM without known DR at baseline who underwent regular screening for DR at the department of ophthalmology.
- Who underwent regular checkups for DR between January 2019 and August 2022 at Dongguk University Ilsan Hospital.
- The controls included patients without DM who presented for regular ophthalmic examination.
Exclusion
- patients with a history of retinal or choroidal diseases (i.e., age-related macular degeneration, retinal vein occlusion, uveitis, retinal detachment, and central serous chorioretinopathy), glaucoma, or optic neuropathy
- patients with neurodegenerative diseases, such as Parkinson's disease and dementia.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
259 Patients enrolled
Trial Details
Trial ID
NCT06150495
Start Date
January 1 2019
End Date
December 31 2025
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongguk University Ilsan Hospital
Goyang-si, Republic of Korea, South Korea, 10324